# Ingersoll Rand Inc.: financial statements, quarterly IR · NYSE · CIK 1699150 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ir.md) · [Financials](/companies/ir/financials.md) · [Filings](/companies/ir/filings.md) · [Insiders](/companies/ir/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ir/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,739](/filings/0001628280-24-044749.md) | [1,821 d](/filings/0001628280-26-008617.md) | [1,670](/filings/0001628280-25-021883.md) | [1,805](/filings/0001628280-25-037049.md) | [1,861](/filings/0001628280-25-047838.md) | [1,899 d](/filings/0001628280-26-008617.md) | [1,717](/filings/0001628280-26-028401.md) | [1,888](/filings/0001628280-26-051415.md) | [1,955](/filings/0001628280-25-047838.md) | [2,091 d](/filings/0001628280-26-008617.md) | [1,847](/filings/0001628280-26-028401.md) | [2,049](/filings/0001628280-26-051415.md) | | Cost of revenue | $m | [1,000](/filings/0001628280-24-044749.md) | [1,040 d](/filings/0001628280-26-008617.md) | [924](/filings/0001628280-25-021883.md) | [1,012](/filings/0001628280-25-037049.md) | [1,046](/filings/0001628280-25-047838.md) | [1,083 d](/filings/0001628280-26-008617.md) | [951](/filings/0001628280-26-028401.md) | [1,063](/filings/0001628280-26-051415.md) | [1,100](/filings/0001628280-25-047838.md) | [1,201 d](/filings/0001628280-26-008617.md) | [1,055](/filings/0001628280-26-028401.md) | [1,186](/filings/0001628280-26-051415.md) | | Gross profit | $m | [739](/filings/0001628280-24-044749.md) | [781 d](/filings/0001628280-26-008617.md) | [746](/filings/0001628280-25-021883.md) | [793](/filings/0001628280-25-037049.md) | [815](/filings/0001628280-25-047838.md) | [815 d](/filings/0001628280-26-008617.md) | [766](/filings/0001628280-26-028401.md) | [825](/filings/0001628280-26-051415.md) | [855](/filings/0001628280-25-047838.md) | [891 d](/filings/0001628280-26-008617.md) | [792](/filings/0001628280-26-028401.md) | [863](/filings/0001628280-26-051415.md) | | Selling, general and administrative | $m | [315](/filings/0001628280-24-044749.md) | [331 d](/filings/0001628280-26-008617.md) | [336](/filings/0001628280-25-021883.md) | [342](/filings/0001628280-25-037049.md) | [334](/filings/0001628280-25-047838.md) | [332 d](/filings/0001628280-26-008617.md) | [350](/filings/0001628280-26-028401.md) | [371](/filings/0001628280-26-051415.md) | [361](/filings/0001628280-25-047838.md) | [357 d](/filings/0001628280-26-008617.md) | [371](/filings/0001628280-26-028401.md) | [401](/filings/0001628280-26-051415.md) | | Operating income | $m | [318](/filings/0001628280-24-044749.md) | [333 d](/filings/0001628280-26-008617.md) | [293](/filings/0001628280-25-021883.md) | [272](/filings/0001628280-25-037049.md) | [356](/filings/0001628280-25-047838.md) | [379 d](/filings/0001628280-26-008617.md) | [303](/filings/0001628280-26-028401.md) | [76.4](/filings/0001628280-26-051415.md) | [376](/filings/0001628280-25-047838.md) | [390 d](/filings/0001628280-26-008617.md) | [290](/filings/0001628280-26-028401.md) | [380](/filings/0001628280-26-051415.md) | | Interest expense | $m | [39.6](/filings/0001628280-23-036698.md) | [37.4 d](/filings/0001628280-24-006642.md) | [36.8](/filings/0001628280-24-020267.md) | [50.8](/filings/0001628280-25-037049.md) | [63.8](/filings/0001628280-25-047838.md) | [61.8 d](/filings/0001628280-26-008617.md) | [61.2](/filings/0001628280-26-028401.md) | [62.7](/filings/0001628280-26-051415.md) | [65.1](/filings/0001628280-25-047838.md) | [64.9 d](/filings/0001628280-26-008617.md) | [63.8](/filings/0001628280-26-028401.md) | [63.3](/filings/0001628280-26-051415.md) | | Income tax | $m | [60.3](/filings/0001628280-24-044749.md) | [71.1 d](/filings/0001628280-26-008617.md) | [54.4](/filings/0001628280-25-021883.md) | [46.1](/filings/0001628280-25-037049.md) | [73.8](/filings/0001628280-25-047838.md) | [88.2 d](/filings/0001628280-26-008617.md) | [58.5](/filings/0001628280-26-028401.md) | [21.0](/filings/0001628280-26-051415.md) | [73.6](/filings/0001628280-25-047838.md) | [66.3 d](/filings/0001628280-26-008617.md) | [36.1](/filings/0001628280-26-028401.md) | [69.1](/filings/0001628280-26-051415.md) | | Net income | $m | [208](/filings/0001628280-24-044749.md) | [230 d](/filings/0001628280-26-008617.md) | [202](/filings/0001628280-25-021883.md) | [185](/filings/0001628280-25-037049.md) | [222](/filings/0001628280-25-047838.md) | [230 d](/filings/0001628280-26-008617.md) | [187](/filings/0001628280-26-028401.md) | [(115)](/filings/0001628280-26-051415.md) | [244](/filings/0001628280-25-047838.md) | [266 d](/filings/0001628280-26-008617.md) | [192](/filings/0001628280-26-028401.md) | [257](/filings/0001628280-26-051415.md) | | Diluted EPS | $ per share | [0.51](/filings/0001628280-24-044749.md) | not reported | [0.50](/filings/0001628280-25-021883.md) | [0.45](/filings/0001628280-25-037049.md) | [0.54](/filings/0001628280-25-047838.md) | not reported | [0.46](/filings/0001628280-26-028401.md) | [(0.29)](/filings/0001628280-26-051415.md) | [0.61](/filings/0001628280-25-047838.md) | not reported | [0.49](/filings/0001628280-26-028401.md) | [0.66](/filings/0001628280-26-051415.md) | | Basic EPS | $ per share | [0.51](/filings/0001628280-24-044749.md) | not reported | [0.50](/filings/0001628280-25-021883.md) | [0.46](/filings/0001628280-25-037049.md) | [0.55](/filings/0001628280-25-047838.md) | not reported | [0.46](/filings/0001628280-26-028401.md) | [(0.29)](/filings/0001628280-26-051415.md) | [0.62](/filings/0001628280-25-047838.md) | not reported | [0.49](/filings/0001628280-26-028401.md) | [0.66](/filings/0001628280-26-051415.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [1.2](/filings/0001628280-23-036698.md) | [1.6](/filings/0001628280-25-006391.md) | [1.5](/filings/0001628280-24-020267.md) | [1.1](/filings/0001628280-24-034400.md) | [1.4](/filings/0001628280-24-044749.md) | [1.5](/filings/0001628280-26-008617.md) | [1.6](/filings/0001628280-25-021883.md) | [1.3](/filings/0001628280-25-037049.md) | [1.2](/filings/0001628280-25-047838.md) | [1.2](/filings/0001628280-26-051415.md) | [1.3](/filings/0001628280-26-028401.md) | [1.2](/filings/0001628280-26-051415.md) | | Current assets | $bn | [3.7](/filings/0001628280-23-036698.md) | [4.1](/filings/0001628280-25-006391.md) | [4.0](/filings/0001628280-24-020267.md) | [3.8](/filings/0001628280-24-034400.md) | [4.2](/filings/0001628280-24-044749.md) | [4.2](/filings/0001628280-26-008617.md) | [4.4](/filings/0001628280-25-021883.md) | [4.2](/filings/0001628280-25-037049.md) | [4.2](/filings/0001628280-25-047838.md) | [4.2](/filings/0001628280-26-051415.md) | [4.3](/filings/0001628280-26-028401.md) | [4.3](/filings/0001628280-26-051415.md) | | Total assets | $bn | [15.2](/filings/0001628280-23-036698.md) | [15.6](/filings/0001628280-25-006391.md) | [18.0](/filings/0001628280-25-021883.md) | [17.8](/filings/0001628280-24-034400.md) | [18.2](/filings/0001628280-24-044749.md) | [18.0](/filings/0001628280-26-008617.md) | [18.4](/filings/0001628280-25-021883.md) | [18.1](/filings/0001628280-25-037049.md) | [18.2](/filings/0001628280-25-047838.md) | [18.3](/filings/0001628280-26-051415.md) | [18.2](/filings/0001628280-26-028401.md) | [18.2](/filings/0001628280-26-051415.md) | | Current liabilities | $bn | [1.7](/filings/0001628280-23-036698.md) | [1.8](/filings/0001628280-25-006391.md) | [1.7](/filings/0001628280-24-020267.md) | [1.8](/filings/0001628280-24-034400.md) | [1.8](/filings/0001628280-24-044749.md) | [1.8](/filings/0001628280-26-008617.md) | [1.8](/filings/0001628280-25-021883.md) | [1.8](/filings/0001628280-25-037049.md) | [1.9](/filings/0001628280-25-047838.md) | [2.1](/filings/0001628280-26-051415.md) | [1.9](/filings/0001628280-26-028401.md) | [2.7](/filings/0001628280-26-051415.md) | | Total liabilities | $bn | [5.5](/filings/0001628280-23-036698.md) | [5.7](/filings/0001628280-25-006391.md) | [5.6](/filings/0001628280-24-020267.md) | [7.8](/filings/0001628280-24-034400.md) | [7.9](/filings/0001628280-24-044749.md) | [7.8](/filings/0001628280-26-008617.md) | [7.8](/filings/0001628280-25-021883.md) | [7.9](/filings/0001628280-25-037049.md) | [8.0](/filings/0001628280-25-047838.md) | [8.1](/filings/0001628280-26-051415.md) | [8.0](/filings/0001628280-26-028401.md) | [8.0](/filings/0001628280-26-051415.md) | | Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $bn | [0.0](/filings/0001628280-23-036698.md) | [0.0](/filings/0001628280-25-006391.md) | [0.0](/filings/0001628280-24-020267.md) | [0.0](/filings/0001628280-24-034400.md) | [0.0](/filings/0001628280-24-044749.md) | [0.0](/filings/0001628280-26-008617.md) | [0.0](/filings/0001628280-25-021883.md) | [0.0](/filings/0001628280-25-037049.md) | [0.0](/filings/0001628280-25-047838.md) | [0.0](/filings/0001628280-26-051415.md) | [0.0](/filings/0001628280-26-028401.md) | [0.7](/filings/0001628280-26-051415.md) | | Short-term borrowings | $bn | [0.0](/filings/0001628280-23-036698.md) | [0.0](/filings/0001628280-25-006391.md) | [0.0](/filings/0001628280-24-020267.md) | [0.0](/filings/0001628280-24-034400.md) | [0.0](/filings/0001628280-24-044749.md) | [0.0](/filings/0001628280-26-008617.md) | [0.0](/filings/0001628280-25-021883.md) | [0.0](/filings/0001628280-25-037049.md) | [0.0](/filings/0001628280-25-047838.md) | [0.0](/filings/0001628280-26-051415.md) | [0.0](/filings/0001628280-26-028401.md) | [0.0](/filings/0001628280-26-051415.md) | | Shareholders' equity | $bn | [9.6](/filings/0001628280-23-036698.md) | [9.8](/filings/0001628280-25-006391.md) | [9.9](/filings/0001628280-24-020267.md) | [10.0](/filings/0001628280-24-034400.md) | [10.3](/filings/0001628280-24-044749.md) | [10.2](/filings/0001628280-26-008617.md) | [10.5](/filings/0001628280-25-021883.md) | [10.1](/filings/0001628280-25-037049.md) | [10.1](/filings/0001628280-25-047838.md) | [10.1](/filings/0001628280-26-051415.md) | [10.2](/filings/0001628280-26-028401.md) | [10.2](/filings/0001628280-26-051415.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: us-gaap:DebtCurrent - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [397 d](/filings/0001628280-24-044749.md) | [581 d](/filings/0001628280-26-008617.md) | [162](/filings/0001628280-25-021883.md) | [305 d](/filings/0001628280-25-037049.md) | [404 d](/filings/0001628280-25-047838.md) | [526 d](/filings/0001628280-26-008617.md) | [256](/filings/0001628280-26-028401.md) | [246 d](/filings/0001628280-26-051415.md) | [355 d](/filings/0001628280-25-047838.md) | [499 d](/filings/0001628280-26-008617.md) | [200](/filings/0001628280-26-028401.md) | [296 d](/filings/0001628280-26-051415.md) | | Capital expenditure | $m | [28.6 d](/filings/0001628280-24-044749.md) | [29.6 d](/filings/0001628280-26-008617.md) | [62.3](/filings/0001628280-25-021883.md) | [21.8](/filings/0001628280-25-037049.md) | [29.7](/filings/0001628280-25-047838.md) | [35.3 d](/filings/0001628280-26-008617.md) | [33.7](/filings/0001628280-26-028401.md) | [35.3](/filings/0001628280-25-037049.md) | [29.1](/filings/0001628280-25-047838.md) | [37.5 d](/filings/0001628280-26-008617.md) | [36.3](/filings/0001628280-26-028401.md) | [27.0 d](/filings/0001628280-26-051415.md) | | Dividends paid | $m | [8.1 d](/filings/0001628280-24-044749.md) | [8.1 d](/filings/0001628280-26-008617.md) | [8.1](/filings/0001628280-25-021883.md) | [8.0 d](/filings/0001628280-25-037049.md) | [8.1 d](/filings/0001628280-25-047838.md) | [8.1 d](/filings/0001628280-26-008617.md) | [8.1](/filings/0001628280-26-028401.md) | [8.0 d](/filings/0001628280-26-051415.md) | [7.9 d](/filings/0001628280-25-047838.md) | [7.8 d](/filings/0001628280-26-008617.md) | [7.8](/filings/0001628280-26-028401.md) | [7.9 d](/filings/0001628280-26-051415.md) | | Share repurchases | $m | [0.1 d](/filings/0001628280-24-044749.md) | [130 d](/filings/0001628280-26-008617.md) | [72.9](/filings/0001628280-25-021883.md) | [62.6 d](/filings/0001628280-25-037049.md) | [62.7 d](/filings/0001628280-25-047838.md) | [62.5 d](/filings/0001628280-26-008617.md) | [10.0](/filings/0001628280-26-028401.md) | [501 d](/filings/0001628280-26-051415.md) | [193 d](/filings/0001628280-25-047838.md) | [315 d](/filings/0001628280-26-008617.md) | [89.5](/filings/0001628280-26-028401.md) | [249 d](/filings/0001628280-26-051415.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [409](/filings/0001628280-23-036698.md) | [409](/filings/0001628280-24-020267.md) | [408](/filings/0001628280-24-034400.md) | [409](/filings/0001628280-24-044749.md) | [408](/filings/0001628280-25-021883.md) | [407](/filings/0001628280-25-037049.md) | [407](/filings/0001628280-25-047838.md) | [406](/filings/0001628280-26-028401.md) | [401](/filings/0001628280-26-051415.md) | [399](/filings/0001628280-25-047838.md) | [394](/filings/0001628280-26-028401.md) | [392](/filings/0001628280-26-051415.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 387,999,429 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0001628280-26-051415.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.